BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu DF, Zheng R, Li A, Zhang JQ. Efficacy of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on proteinuria and weight in a diabetes cohort. World J Diabetes 2025; 16(2): 98552 [PMID: 39959283 DOI: 10.4239/wjd.v16.i2.98552]
URL: https://www.wjgnet.com/1948-9358/full/v16/i2/98552.htm
Number Citing Articles
1
Giancarlo Bilancio, Sarah Hamzeh, Nicoletta Vecchione, Dora Russo, Candida Iacuzzo, Luca Apicella, Renata Angela Di Pietro, Piercarla Vitale, Maria Amicone, Antonio Pisani, Massimo Cirillo, Carmine Secondulfo. Dapagliflozin’s Effects on Urinary Albumin and Non-Albumin Proteins in Diabetic and Non-Diabetic Kidney Transplant RecipientsBiomedicines 2025; 13(6): 1303 doi: 10.3390/biomedicines13061303
2
Ali Talyshinskii, Vineet Gauhar, Steffi Kar Kei Yuen, Selcuk Güven, Theodoros Tokas, Arman Tsaturyan, Dmitry Enikeev, Bhaskar Somani. From molecules to the clinic—pathophysiology of sodium-glucose cotransporter 2 inhibitors and their emerging role in urology: A comprehensive review from the European Association of Urology Section of EndourologyAsian Journal of Urology 2026;  doi: 10.1016/j.ajur.2025.11.004